Novel combination treatment of CDK 4/6 inhibitors with PARP inhibitors in triple negative breast cancer cells

dc.date.accessioned	2023-03-06T07:32:20Z
dc.date.available	2023-03-06T07:32:20Z
dc.date.issued	2023
dc.identifier.citation	Naunyn Schmiedebergs Arch Pharmacol. 2023 Jan 4. doi: 10.1007/s00210-022-02375-4. Online ahead of print.
dc.identifier.uri	https://hdl.handle.net/20.500.12619/100277
dc.relation.isversionof	10.1007/s00210-022-02375-4
dc.relation.isversionof	10.1007/s00210-022-02375-4
dc.title	Novel combination treatment of CDK 4/6 inhibitors with PARP inhibitors in triple negative breast cancer cells
dc.relation.journal	Naunyn Schmiedebergs Arch Pharmacol
dc.identifier.doi	10.1007/s00210-022-02375-4
dc.contributor.author	Guney Eskiler G
dc.contributor.author	Guney Eskiler G
dc.contributor.author	Ozman Z
dc.contributor.author	Haciefendi A
dc.contributor.author	Cansaran-Duman D.